Dimiracetam is a nootropic drug belonging to the racetam family, with potential applications in treating neuropathic pain.
Dimiracetam has been studied for its anti-neuropathic activity, showing efficacy in inhibiting hypersensitivity and neurological alterations in animal models.
It is also being investigated for its potential in treating conditions like AIDS-related neuropathy. Its mechanism of action and pharmacokinetic properties remain under investigation.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | Dimiracetam [INN], UNII-4AW7F70MZO, 4AW7F70MZO |
|---|---|
| IUPAC Name | 3, 6, 7, 7a-tetrahydro-1H-pyrrolo[1, 2-a]imidazole-2, 5-dione |
| CAS | 126100-97-8 |
| Molecular Weight | 140.14 |
| Molecular Formula | C6H8N2O2 |
| SMILES | C1CC(=O)N2C1NC(=O)C2 |